NEWRON PHARMACEUTICALS S.P.A. EUR0.20NEWRON PHARMACEUTICALS S.P.A. EUR0.20NEWRON PHARMACEUTICALS S.P.A. EUR0.20

NEWRON PHARMACEUTICALS S.P.A. EUR0.20

No trades
See on Supercharts

0QOI fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
0QOI has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company